BCM
TNGX icon

Boxer Capital Management’s Tango Therapeutics TNGX Stock Holding History

Boxer Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340M Hold
10,876,219
– – 25.61% 1
2026
Q1 		$228M Hold
10,876,219
– – 29.87% 1
2025
Q4 		$96.4M Buy
10,876,219
+1,104,734
+11% +$9.52M 21.09% 1
2025
Q3 		$82.1M Hold
9,771,485
– – 26.16% 1
2025
Q2 		$50M Sell
9,771,485
-609,514
-6% -$1.51M 25.18% 1
2025
Q1 		$14.2M Hold
10,380,999
– – 4.28% 10
2024
Q4 		$32.1M Buy
+10,380,999
New +$48.2M 2.73% 9

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boxer Capital Management's TNGX Position: Q2 2026 in Review

Boxer Capital Management held its Tango Therapeutics (TNGX) position steady in Q2 2026 at 10,876,219 shares worth $340M. The position accounts for 25.61% of the portfolio, ranked #1.

Boxer Capital Management first reported a position in TNGX in Q4 2024 and has held it in 7 quarters since. 247 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Boxer Capital Management held 10,876,219 shares of Tango Therapeutics worth $340M as of Q2 2026.
  • Boxer Capital Management left its Tango Therapeutics share count unchanged in Q2 2026.
  • Tango Therapeutics made up 25.61% of Boxer Capital Management's portfolio in Q2 2026, its #1 holding.
  • Boxer Capital Management first reported a position in Tango Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 247 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Boxer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.